BridgeBio Oncology Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of small-molecule therapeutics for the treatment of renin-angiotensin system and phosphoinositide 3-kinase malignancies in the United ...
Leadership
Neil Kumar Ph.D.
Executive Chairman
Frank P. McCormick Ph.D.Founder
Co-Founder, Non-Executive Director & Chair of the Advisory Board
Yong Ben M.B.A., M.D.
Chief Medical & Development Officer
Pedro J. Beltran M.D., Ph.D.
Chief Executive Officer and Director
Marc Cobo
VP of Finance & Controller
Idan Elmelech M.A., M.B.A.
Chief Operating Officer
Aaron Chan J.D.
Vice President of Legal
Bin Wang Ph.D.
Senior Vice President of Drug Discovery
Daniel Watson Ph.D.
Senior Vice President of Chemistry, Manufacturing & Controls
